🔗 Share this article Social Media Influencers Fueling Parallel Trade for Unapproved Weight-Loss Drug An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings. Experimental Treatment Gaining Traction Online The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes. Thriving Trade on Social Networks Separately, a robust market exists on messaging services, where communities with numerous of members share comparison photos, administration instructions and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to WhatsApp for transactions. Understanding The Experimental Drug This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic. Medical Experts Voice Concerns However, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering substances of uncertain source. Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro. Regulatory Position and Implementation Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the British medical regulations. Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and customer regulations, risking penalties, prosecution or prison. Platform Response and Material Removal Based on the social media company, the platform has taken down problematic content and banned associated keywords and search suggestions. The company said it was dedicated to keeping the service secure and allocating resources in strengthening compliance measures. Online Trading Activities Investigations also found communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with images of slimming results, glowing reviews and detailed guides for mixing or administering at residence. Within moments of entering one group, a seller shared contact information, where most purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, health issues or previous experience. Item Details and Pricing Within these communities, messages show dark colored parcels with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.” Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”. Service Moderation and Safety Measures A representative for the messaging service stated it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”. Healthcare Professional Warnings “People are injecting materials they can’t verify. Although the research behind this drug is valid, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said. Her team has previously encountered individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.” Manufacturer Position A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to potentially serious medical dangers”.